Valenti L - Search Results

1

Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease.

Pulixi EA, Tobaldini E, Battezzati PM, D'Ingianna P, Borroni V, Fracanzani AL, Maggioni M, Pelusi S, Bulgheroni M, Zuin M, Fargion S, Montano N, Valenti L. Pulixi EA, et al. Among authors: valenti l. PLoS One. 2014 Apr 24;9(4):e96349. doi: 10.1371/journal.pone.0096349. eCollection 2014. PLoS One. 2014. PMID: 24763757 Free PMC article.

2

Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells.

Scaccabarozzi A, Arosio P, Weiss G, Valenti L, Dongiovanni P, Fracanzani AL, Mattioli M, Levi S, Fiorelli G, Fargion S. Scaccabarozzi A, et al. Among authors: valenti l. Br J Haematol. 2000 Sep;110(4):978-84. doi: 10.1046/j.1365-2141.2000.02280.x. Br J Haematol. 2000. PMID: 11054092 Free article.

3

Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia.

Fargion S, Valenti L, Fracanzani AL, Sampietro M, Cappellini MD, Scaccabarozzi A, Soligo D, Mariani C, Fiorelli G. Fargion S, et al. Among authors: valenti l. Blood. 2000 Nov 15;96(10):3653-5. Blood. 2000. PMID: 11071669 Free article.

4

Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.

Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G. Fargion S, et al. Among authors: valenti l. Blood. 2001 Jun 15;97(12):3707-12. doi: 10.1182/blood.v97.12.3707. Blood. 2001. PMID: 11389006 Free article.

5

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.

Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Fargion S, et al. Among authors: valenti l. Am J Gastroenterol. 2001 Aug;96(8):2448-55. doi: 10.1111/j.1572-0241.2001.04052.x. Am J Gastroenterol. 2001. PMID: 11513189

6

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Gastroenterology. 2002 Feb;122(2):274-80. doi: 10.1053/gast.2002.31065. Gastroenterology. 2002. PMID: 11832442

7

Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance.

Valenti L, Fracanzani AL, Fargion S. Valenti L, et al. Gastroenterology. 2003 Mar;124(3):866; author reply 866-7. doi: 10.1053/gast.2003.50130. Gastroenterology. 2003. PMID: 12612935 No abstract available.

8

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Dig Liver Dis. 2003 Mar;35(3):172-8. doi: 10.1016/s1590-8658(03)00025-2. Dig Liver Dis. 2003. PMID: 12779071

9

What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

Zavaroni I, Numeroso F, Dongiovanni P, Ardigò D, Valenti L, Fracanzani Al, Valtuena S, Delsignore R, Fargion S, Reaven GM. Zavaroni I, et al. Among authors: valenti l. Metabolism. 2003 Dec;52(12):1593-6. doi: 10.1016/s0026-0495(03)00329-9. Metabolism. 2003. PMID: 14669161 Clinical Trial.

10

TNFalpha promoter polymorphisms.

Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. Fargion S, et al. Among authors: valenti l. Methods Mol Med. 2004;98:47-58. doi: 10.1385/1-59259-771-8:047. Methods Mol Med. 2004. PMID: 15064432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page